Alx Oncology Holdings (ALXO) Other Non-Current Assets (2019 - 2026)

Alx Oncology Holdings' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 54.94% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (down 54.94% YoY), while the FY2025 annual figure was $3.6 million, down 48.17% from the prior year.
• Other Non-Current Assets came in at $2.9 million for Q1 2026 at Alx Oncology Holdings, down from $3.6 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $16.3 million in Q3 2022 to a low of $66000.0 in Q2 2022.
• A 5-year average of $10.0 million and a median of $11.0 million in 2023 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets slumped 99.25% in 2022 and jumped 16409.09% in 2023, its largest moves.
• Alx Oncology Holdings' Other Non-Current Assets stood at $14.9 million in 2022, then retreated by 0.25% to $14.9 million in 2023, then tumbled by 53.04% to $7.0 million in 2024, then tumbled by 48.17% to $3.6 million in 2025, then fell by 19.14% to $2.9 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.9 million, $3.6 million, and $9.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison